Literature DB >> 12471576

Regional occurrence of plasmid-mediated SHV-7, an extended-spectrum beta-lactamase, in Enterobacter cloacae in Philadelphia Teaching Hospitals.

Matthew E Levison1, Yamini V Mailapur, Sandeep K Pradhan, George A Jacoby, Pamela Adams, Christopher L Emery, Phyllis L May, Peter G Pitsakis.   

Abstract

Although the production of extended-spectrum beta-lactamases (ESBLs) by Klebsiella pneumoniae and Escherichia coli is an emerging problem, limited data are available regarding the frequency of ESBL production in other organisms. We provide the only description of regional occurrence of SHV-7 in Enterobacteriaceae other than E. coli or K. pneumoniae in the United States, and we emphasize that, among Enterobacter cloacae strains, not all resistance to extended-spectrum cephalosporins is the result of hyperproduction of AmpC beta-lactamase.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12471576     DOI： 10.1086/344178

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  8 in total

1.  Extended-spectrum beta-lactamases among Enterobacter isolates obtained in Tel Aviv, Israel.

Authors:  Jacob Schlesinger; Shiri Navon-Venezia; Inna Chmelnitsky; Orly Hammer-Münz; Azita Leavitt; Howard S Gold; Mitchell J Schwaber; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

2.  Molecular analysis of the simultaneous production of two SHV-type extended-spectrum beta-lactamases in a clinical isolate of Enterobacter cloacae by using single-nucleotide polymorphism genotyping.

Authors:  Dóra Szabó; Melissa A Melan; Andrea M Hujer; Robert A Bonomo; Kristine M Hujer; Christopher R Bethel; Katalin Kristóf; David L Paterson
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

3.  SHV-type extended-spectrum beta-lactamase production is associated with Reduced cefepime susceptibility in Enterobacter cloacae.

Authors:  Dóra Szabó; Robert A Bonomo; Fernanda Silveira; A William Pasculle; Carla Baxter; Peter K Linden; Andrea M Hujer; Kristine M Hujer; Kathleen Deeley; David L Paterson
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

4.  qnrB, another plasmid-mediated gene for quinolone resistance.

Authors:  George A Jacoby; Kelley E Walsh; Debra M Mills; Victoria J Walker; Herin Oh; Ari Robicsek; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

Review 5.  Extended-spectrum beta-lactamases: a clinical update.

Authors:  David L Paterson; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

6.  Infections with VIM-1 metallo-{beta}-lactamase-producing enterobacter cloacae and their correlation with clinical outcome.

Authors:  Marco Falcone; Maria Lina Mezzatesta; Mariagrazia Perilli; Chiara Forcella; Alessandra Giordano; Viviana Cafiso; Gianfranco Amicosante; Stefania Stefani; Mario Venditti
Journal:  J Clin Microbiol       Date:  2009-09-09       Impact factor: 5.948

7.  Characterization of Enterobacter cloacae and Citrobacter freundii species complex isolates with decreased susceptibility to cephalosporins from United States hospitals and activity of ceftazidime/avibactam and comparator agents.

Authors:  Helio S Sader; Rodrigo E Mendes; Timothy B Doyle; Andrew P Davis; Mariana Castanheira
Journal:  JAC Antimicrob Resist       Date:  2021-08-20

8.  Superintendence of antimicrobial resistance observed in bacterial flora isolated from human faecal carriage in Vellore, India.

Authors:  Sundera Raj Esther Priyadharshini; Chidamabram Ramalingam; Balasubramanian Ramesh
Journal:  Saudi J Biol Sci       Date:  2015-11-24       Impact factor: 4.219
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.